Predicting progression to Alzheimer's disease dementia using cognitive measures

被引:5
|
作者
Macdougall, Amy [1 ]
Whitfield, Tim [2 ]
Needham, Kelly [3 ]
Schott, Jonathan M. [4 ]
Frost, Chris [1 ]
Walker, Zuzana [2 ,5 ]
机构
[1] London Sch Hyg & Trop Med, Dept Med Stat, London, England
[2] UCL, Div Psychiat, Sixth Floor,Maple House,149 Tottenham Court Rd, London W1T 7NF, England
[3] Univ Sheffield, Sch Hlth & Related Res ScHARR, Sheffield, England
[4] UCL Queen Sq Inst Neurol, Dementia Res Ctr, London, England
[5] Essex Partnership Univ NHS Fdn Trust, Wickford, England
关键词
Alzheimer's disease; clinical progression; mild cognitive impairment; neuropsychological tests; subjective cognitive decline; MINI-MENTAL-STATE; IMPAIRMENT; ANXIETY; ENGLISH; DECLINE; SCALE; TRAIL; RISK;
D O I
10.1002/gps.6067
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
ObjectivesIt is important to determine if cognitive measures identified as being prognostic in dementia research cohorts also have utility in memory clinics. We aimed to identify measures with the greatest power to predict future Alzheimer's disease (AD) dementia in a clinical setting where expensive biomarkers are not widely available.MethodsThis study utilized routine Memory Clinic data collected over 18 years. From 2214 patients assessed in the clinic, we selected 328 patients with an initial diagnosis of subjective cognitive decline or mild cognitive impairment. We compared two types of statistical model for the prediction of AD dementia. The first model included baseline cognitive test scores only, while the second model also included change scores between baseline and the first follow-up.ResultsBaseline scores on tests of global cognitive function (Mini-mental state examination and Cambridge Cognitive Examination-Revised), verbal episodic memory and psychomotor speed were the best predictors of conversion to AD dementia. The inclusion of cognitive change scores over 1 year of follow-up improved predictive accuracy versus baseline scores alone.ConclusionsWe found that the best cognitive predictors of AD dementia in a clinical setting were similar to those previously identified using research cohorts. Taking change in cognitive function into account enabled the onset of AD dementia to be predicted with greater accuracy. Whilst biomarkers of Alzheimer's disease (AD) and neurodegeneration are advancing, these are not available in all settings Cognitive tests are more widely available We evaluated the prognostic utility of cognitive tests to predict incident AD dementia in a combined memory clinic sample of patients with subjective cognitive decline (SCD) or mild cognitive impairment (MCI) A statistical model including change in cognition (from first to second assessment) alongside baseline scores was able to predict AD more accurately versus baseline scores alone
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Erratum to: Predicting progression of Alzheimer's disease
    Rachelle S Doody
    Valory Pavlik
    Paul Massman
    Susan Rountree
    Eveleen Darby
    Wenyaw Chan
    Alzheimer's Research & Therapy, 2 (3)
  • [22] Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer's disease
    Dansson, Hakon Valur
    Stempfle, Lena
    Egilsdottir, Hildur
    Schliep, Alexander
    Portelius, Erik
    Blennow, Kaj
    Zetterberg, Henrik
    Johansson, Fredrik D.
    ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
  • [23] Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
    Hákon Valur Dansson
    Lena Stempfle
    Hildur Egilsdóttir
    Alexander Schliep
    Erik Portelius
    Kaj Blennow
    Henrik Zetterberg
    Fredrik D. Johansson
    Alzheimer's Research & Therapy, 13
  • [24] Predicting age at Alzheimer's dementia onset with the cognitive clock
    Yu, Lei
    Wang, Tianhao
    Wilson, Robert S.
    Guo, Wensheng
    Aggarwal, Neelum T.
    Bennett, David A.
    Boyle, Patricia A.
    ALZHEIMERS & DEMENTIA, 2023, 19 (08) : 3555 - 3562
  • [25] Slowing the progression of cognitive decline in alzheimer’s disease using mifepristone
    Joseph K. Belanoff
    Jennifer Jurik
    Lindsey D. Schatzberg
    Charles DeBattista
    Alan F. Schatzberg
    Journal of Molecular Neuroscience, 2002, 19 : 201 - 206
  • [26] Slowing the progression of cognitive decline in Alzheimer's disease using mifepristone
    Belanoff, JK
    Jurik, J
    Schatzberg, LD
    DeBattista, C
    Schatzberg, AF
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2002, 19 (1-2) : 201 - 206
  • [27] Predicting Alzheimer's disease by cognitive tests
    Quinn, M
    LANCET, 1996, 347 (9006): : 958 - 958
  • [28] Predicting Alzheimer disease dementia
    Sarah Crunkhorn
    Nature Reviews Drug Discovery, 2021, 20 (7) : 508 - 508
  • [29] Predicting Conversion from Subjective Cognitive Decline to Mild Cognitive Impairment and Alzheimer's Disease Dementia Using Ensemble Machine Learning
    Dolcet-Negre, Marta M.
    Aguayo, Laura Imaz
    Garcia-De-Eulate, Reyes
    Marti-Andres, Gloria
    Fernandez-Matarrubia, Marta
    Dominguez, Pablo
    Fernandez-Seara, Maria A.
    Riverol, Mario
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 93 (01) : 125 - 140
  • [30] Progression to Dementia in Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease
    Hamilton, Calum A.
    Matthews, Fiona E.
    Donaghy, Paul C.
    Taylor, John-Paul
    O'Brien, John T.
    Barnett, Nicola
    Olsen, Kirsty
    Durcan, Rory
    Roberts, Gemma
    Ciafone, Joanna
    Barker, Sally A. H.
    Firbank, Michael
    McKeith, Ian G.
    Thomas, Alan J.
    NEUROLOGY, 2021, 96 (22) : E2685 - E2693